(Q81223393)

English

Phase 1 study of ABT-751, a novel microtubule inhibitor, in patients with refractory hematologic malignancies

scientific article published on 01 September 2005

Statements

Phase 1 study of ABT-751, a novel microtubule inhibitor, in patients with refractory hematologic malignancies (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit